XOMA Acquires Royalty and Milestone Economics to Phase 3 First-In-Class Orphan Disease Asset for Niemann-Pick Disease Type C (NPC) and Phase 2 Oncology Asset Jun 22, 2023 7:30am EDT
XOMA Reports First Quarter 2023 Financial Results and Provides Update on the Acceleration of its Differentiated Royalty Monetization Strategy May 09, 2023 7:30am EDT
XOMA Acquires Cashflow-Generating Asset for its Royalty and Milestone Portfolio Mar 30, 2023 7:30am EDT
XOMA Reports Full-Year 2022 Financial Results and Provides Update to the Acceleration of its Differentiated Royalty Monetization Strategy Mar 09, 2023 7:30am EST
XOMA Announces New Employment Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Jan 06, 2023 7:00pm EST
